NASDAQ:XLO | Income Statement | Xilio Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$18.69M$14.56M$22.18M-$3.49M-$2.88M-$6.37M-$0.33-$0.3319,404,688
2026-03-31$12.65M$19.83M$26.76M-$14.11M$4.58M-$9.53M-$0.58-$0.5816,347,538
2025-12-31$13.69M$18.12M$25.52M-$11.84M$22.2M$10.36M-$3.76-$3.76-96,980,096
2025-09-30$19.07M$14.32M$21M-$1.93M-$14.36M-$16.29M-$0.11-$0.11144,106,869
2025-06-30$8.08M$15.33M$22.45M-$14.37M-$1.48M-$15.84M-$2.30-$2.306,889,119
2025-03-31$2.93M$8.27M$16.78M-$13.85M$586,000.00-$13.27M-$2.49-$2.495,335,740
2024-12-31$1.72M$8.84M$15.35M-$13.63M$536,000.00-$13.09M-$14.33-$14.33-45,940,556
2024-09-30$2.26M$10.76M$17.03M-$14.76M$742,000.00-$14.02M-$0.22-$0.2263,465,063
2024-06-30$2.36M$11.22M$17.06M-$14.7M$779,000.00-$13.93M-$0.24-$0.2457,760,178
2024-03-31$10.4M$17.49M-$17.49M$284,000.00-$17.2M-$0.62-$0.6227,912,584
2023-12-31$11.74M$18.13M-$18.13M$475,000.00-$17.66M-$0.64-$0.6420,528
2023-09-30$11.05M$17.36M-$17.36M$613,000.00-$16.75M-$0.61-$0.6127,523,821
2023-06-30$13.22M$20.12M-$20.12M$761,000.00-$19.36M-$0.70-$0.7027,468,668
2023-03-31$16.13M$23.53M-$23.53M$880,000.00-$22.65M-$0.83-$0.8327,433,252
2022-12-31$15M$23.17M-$23.17M$701,000.00$0.00-$22.47M-$0.82-$0.828,002
2022-09-30$13.04M$20.21M-$20.21M$416,000.00-$19.79M-$0.72-$0.7227,399,906
2022-06-30$16.25M$24.55M-$24.55M-$61,000.00-$24.61M-$0.90-$0.9027,384,614
2022-03-31$14.92M$21.22M-$21.22M-$129,000.00$0.00-$21.35M-$0.78-$0.7827,367,377
2021-12-31$11.35M$19.56M-$19.56M-$145,000.00$0.00-$19.7M$62.66$62.664,869,892
2021-09-30$10.47M$15.96M-$15.96M-$290,000.00-$16.25M-$21.27-$21.27763,869
2021-06-30$17.75M$23.01M-$23.01M-$174,000.00-$23.18M-$31.48-$31.48736,473
2021-03-31$11.62M$16.52M-$16.52M$0.00-$16.67M-$23.53-$23.53708,264
2020-12-31$17.67M$20.6M-$20.6M$0.00-$20.77M-$33.40-$33.4045,503
2020-09-30$11.46M$14.62M-$14.62M-$14.82M-$24.19-$24.19612,657
2020-06-30-$11.51M
2020-03-31-$8.12M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$43.77M$56.04M$85.75M-$41.98M$6.95M-$35.04M$0.00-$35.04M-$4.19-$4.198,359,109
2024-12-31$6.34M$41.21M$66.93M-$60.58M$2.34M-$58.24M$0.00-$58.24M-$15.24-$15.243,822,244
2023-12-31$52.14M$79.13M-$79.13M$2.73M$0.00-$76.4M-$2.78-$2.7827,496,107
2022-12-31$59.2M$89.15M-$89.15M$927,000.00$0.00-$88.22M-$3.22-$3.2227,392,087
2021-12-31$51.19M$75.04M-$75.04M-$756,000.00$0.00-$75.8M-$13.52-$13.525,606,308
2020-12-31$43.91M$54.56M-$54.56M$0.00-$55.22M-$105.42-$105.42523,786

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.